These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 25065972

  • 21. [Extension study and evaluation of the therapeutic response in a patient with metastatic lung adenocarcinoma using sequential study with ¹⁸F-FDG PET-CT and ¹⁸F-fluoride PET-CT].
    Moragas M, Soler M, Riera E, García JR.
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):45-8. PubMed ID: 24690280
    [Abstract] [Full Text] [Related]

  • 22. [A case of neurolymphomatosis diagnosed with FDG-PET].
    Hoshikawa Y, Oguri T, Hattori M, Uematsu N, Matsukawa N, Yamawaki T, Kusumoto S, Ojika K.
    Rinsho Shinkeigaku; 2007 Jul; 47(7):437-40. PubMed ID: 17710889
    [Abstract] [Full Text] [Related]

  • 23. Pericardial involvement in a non-Hodgkin lymphoma patient: coregistered FDG-PET and CT imaging.
    Weijs LE, Arsos G, Baarslag HJ, Wittebol S, de Klerk JM.
    Eur Heart J; 2007 Nov; 28(22):2698. PubMed ID: 17567624
    [No Abstract] [Full Text] [Related]

  • 24. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
    Cho SF, Chang CC, Liu YC, Chang CS, Hsiao HH, Liu TC, Huang CT, Lin SF.
    Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
    [Abstract] [Full Text] [Related]

  • 25. [Primary renal lymphoma].
    Torrecilla García-Ripoll JR, Pascual Samaniego M, Martín Blanco S, Rivera Ferro J, Peral Martínez JI, Fernández del Busto E.
    Actas Urol Esp; 2003 Mar; 27(7):555-8. PubMed ID: 12938588
    [Abstract] [Full Text] [Related]

  • 26. Early interim PET/CT predicts post-treatment response in diffuse large B-cell lymphoma.
    Wu X, Pertovaara H, Korkola P, Vornanen M, Järvenpää R, Dastidar P, Eskola H, Kellokumpu-Lehtinen PL.
    Acta Oncol; 2014 Aug; 53(8):1093-9. PubMed ID: 24960581
    [Abstract] [Full Text] [Related]

  • 27. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
    Avivi I, Zilberlicht A, Dann EJ, Leiba R, Faibish T, Rowe JM, Bar-Shalom R.
    Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
    [Abstract] [Full Text] [Related]

  • 28. 18F-FDG-PET/CT Pulmonary Infiltrates in Non-Hodgkin Lymphoma Patients Treated with Combined Immunochemotherapy: Incidence and Clinical Characteristics.
    Cohen YC, Berger T, Eshel L, Stern D, Bairey O, Raanani P, Shpilberg O.
    Isr Med Assoc J; 2017 Jun; 19(6):372-377. PubMed ID: 28647936
    [Abstract] [Full Text] [Related]

  • 29. Primary lymphoma of the kidney. Report of a case and update of the literature.
    Porcaro AB, D'Amico A, Novella G, Curti P, Ficarra V, Antoniolli SZ, Martignoni G, Matteo B, Malossini G.
    Arch Ital Urol Androl; 2002 Mar; 74(1):44-7. PubMed ID: 12053451
    [Abstract] [Full Text] [Related]

  • 30. 18F-FDG PET/CT in primary non-Hodgkin's lymphoma of the sinonasal tract.
    Tempescul A, Querellou S, Ianotto JC, Boisramé S, Valette G, Berthou C.
    Ann Hematol; 2010 Jun; 89(6):635-7. PubMed ID: 19844711
    [No Abstract] [Full Text] [Related]

  • 31. Role of 18F-FDG PET/CT in primary brain lymphoma.
    de-Bonilla-Damiá Á, Fernández-López R, Capote-Huelva FJ, de la Cruz-Vicente F, Egea-Guerrero JJ, Borrego-Dorado I.
    Rev Esp Med Nucl Imagen Mol; 2017 Jun; 36(5):298-303. PubMed ID: 28438519
    [Abstract] [Full Text] [Related]

  • 32. False-positive FDG-PET findings due to bone metastasis from prostate cancer in staging of non-Hodgkin's lymphoma.
    Inoue Y, Tamaki H, Yamagami T, Iwasaki H, Nakatsuka S, Soma T.
    Eur J Haematol; 2007 Jul; 79(1):88-90. PubMed ID: 17532762
    [No Abstract] [Full Text] [Related]

  • 33. 18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
    Kumar R, Xiu Y, Zhuang HM, Alavi A.
    Br J Dermatol; 2006 Aug; 155(2):357-63. PubMed ID: 16882175
    [Abstract] [Full Text] [Related]

  • 34. FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.
    Kostakoglu L, Goldsmith SJ, Leonard JP, Christos P, Furman RR, Atasever T, Chandramouly A, Verma S, Kothari P, Coleman M.
    Cancer; 2006 Dec 01; 107(11):2678-87. PubMed ID: 17063502
    [Abstract] [Full Text] [Related]

  • 35. Bilateral primary renal non-Hodgkin's lymphoma presenting with acute renal failure: successful treatment with systemic chemotherapy.
    Choi JH, Choi GB, Shim KN, Sung SH, Han WS, Baek SY.
    Acta Haematol; 1997 Dec 01; 97(4):231-5. PubMed ID: 9158668
    [Abstract] [Full Text] [Related]

  • 36. Primary renal non-Hodgkin's lymphoma - a difficult differential diagnosis.
    Gellrich J, Hakenberg OW, Naumann R, Manseck A, Lossnitzer A, Wirth MP.
    Onkologie; 2002 Jun 01; 25(3):273-7. PubMed ID: 12119463
    [Abstract] [Full Text] [Related]

  • 37. Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants.
    Trotman J, Fournier M, Lamy T, Seymour JF, Sonet A, Janikova A, Shpilberg O, Gyan E, Tilly H, Estell J, Forsyth C, Decaudin D, Fabiani B, Gabarre J, Salles B, Van Den Neste E, Canioni D, Garin E, Fulham M, Vander Borght T, Salles G.
    J Clin Oncol; 2011 Aug 10; 29(23):3194-200. PubMed ID: 21747087
    [Abstract] [Full Text] [Related]

  • 38. Unusual ¹⁸F-FDG PET/CT finding of an oxyphil parathyroid adenoma in a patient with Hodgkin's Lymphoma.
    Niccoli-Asabella A, Ferrari C, Antonica F, Scardapane A, Rubini D, Rubini G.
    Rev Esp Med Nucl Imagen Mol; 2014 Aug 10; 33(6):370-3. PubMed ID: 24618092
    [Abstract] [Full Text] [Related]

  • 39. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
    Karantanis D, O'Neill BP, Subramaniam RM, Peller PJ, Witte RJ, Mullan BP, Wiseman GA.
    Clin Nucl Med; 2007 Apr 10; 32(4):271-4. PubMed ID: 17413571
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.
    Tsuji K, Kishi S, Tsuchida T, Yamauchi T, Ikegaya S, Urasaki Y, Fujiwara Y, Ueda T, Okazawa H, Kimura H.
    J Magn Reson Imaging; 2015 Jun 10; 41(6):1601-7. PubMed ID: 25111444
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.